Akers Biosciences Reports Fiscal Year 2018 Earnings
01 avr. 2019 17h31 HE
|
Akers Biosciences Inc.
Ongoing Measures to Streamline Operations, Reduce Costs and Position the Company for Strategic Alternatives THOROFARE, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc....
Akers Biosciences Exploring Potential Business Combinations in Alternative Sectors Including Cannabis Industry
19 nov. 2018 09h01 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, is...
Akers Biosciences Announces Q3 2018 Earnings
15 nov. 2018 07h00 HE
|
Akers Biosciences Inc.
Sales of Flagship PIFA Heparin PF/4 Rapid Assay Products Up 16% over Q3 2017; Company Continuing to Evaluate Strategic Alternatives to Maximize Shareholder Value THOROFARE, N.J., Nov. 15, 2018 ...
Akers Biosciences Announces Intention to Explore Strategic Alternatives to Maximize Shareholder Value
07 nov. 2018 09h15 HE
|
Akers Biosciences Inc
Announces 1:8 Reverse Stock Split THOROFARE, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid...
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
08 oct. 2018 02h00 HE
|
Akers Biosciences Inc
THOROFARE, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Akers Biosciences Announces Q2 and H1 2018 Earnings
14 août 2018 16h18 HE
|
Akers Biosciences Inc
THOROFARE, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, reports...
Akers Biosciences Announces Lifting of Temporary Suspension of Trading on the London Stock Exchange
26 juil. 2018 07h00 HE
|
Akers Biosciences Inc
THOROFARE, N.J., July 26, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Akers Biosciences Signs a Further Independent Sales Representative Organization for Heparin PF4 Rapid Test Covering Additional 12 States
18 juil. 2018 07h01 HE
|
Akers Biosciences Inc
THOROFARE, N.J.,, July 18, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Akers Biosciences Announces Q1 2018 Earnings
13 juil. 2018 19h12 HE
|
Akers Biosciences Inc
THOROFARE, N.J, July 13, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, reports...
Akers Biosciences Files Restated Previously Issued Financial Statements for 2017
13 juil. 2018 18h24 HE
|
Akers Biosciences Inc
THOROFARE, N.J, July 13, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers”, “Akers Bio” or the "Company"), a developer of rapid health information technologies,...